Literature DB >> 12537263

Hip involvement in patients with familial Mediterranean fever. A review of ten cases.

Mohamed Younes1, Marcel-Francis Kahn, Olivier Meyer.   

Abstract

Hip involvement is uncommon in familial Mediterranean fever (FMF) and can result either from a process specific to this disease or from a coexisting chronic inflammatory joint disease, usually suggestive of ankylosing spondylitis (AS). We report ten cases of FMF with radiologically-documented inflammatory hip disease. Five patients had AS and one had juvenile idiopathic arthritis. There were six men and four women, with a mean age of 34.4 years +/- 17.6 (range, 15-70 years). Onset of the inflammatory hip disease occurred after bouts of acute hip symptoms in one of the patients with isolated FMF and after protracted hip arthritis in another; the two other patients had no history of hip symptoms. The HLA-B27 antigen was looked for in two of the five patients with FMF and AS, with negative results in both; another patient in this subgroup had severe ulcerative colitis. Total hip replacement or replacement of the acetabulum was required in six patients, including two with isolated FMF. Chronic joint disease has been estimated to contribute fewer than 5% of the joint manifestations in FMF. In previous studies, the hips and knees were affected in 75% of patients with chronic joint disease related to FMF. The association of FMF and AS (usually without the HLA-B27 antigen) has been well documented, although the pathogenic mechanisms that link these two conditions remain unknown.

Entities:  

Mesh:

Year:  2002        PMID: 12537263     DOI: 10.1016/s1297-319x(02)00452-9

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  15 in total

1.  Avascular necrosis of the femoral head foreshadowing familial Mediterranean fever: apropos of three cases.

Authors:  Ahmet Mesut Onat; Levent Ozçakar; Kemal Ureten; Sedat Kiraz; Ihsan Ertenli; Meral Calgüneri
Journal:  Clin Rheumatol       Date:  2004-09-04       Impact factor: 2.980

Review 2.  Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: A case report and review of the literature.

Authors:  Işik Keleş; Gülümser Aydin; Aliye Tosun; Elem Inal; Hatice Keleş; Sevim Orkun
Journal:  Rheumatol Int       Date:  2005-11-24       Impact factor: 2.631

3.  A Case Report of Familial Mediterranean Fever Diagnosed Following the Total Knee Arthroplasty.

Authors:  Sumito Kawamura; Kazunaga Agematsu; Daisuke Kawamura; Goroh Kawamura; Koji Suzuki; Michio Minami
Journal:  HSS J       Date:  2015-05-12

Review 4.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

5.  Familial Mediterranean fever responds well to infliximab: single case experience.

Authors:  Salih Ozgocmen; Levent Ozçakar; Ozge Ardicoglu; Ercan Kocakoc; Arzu Kaya; Adem Kiris
Journal:  Clin Rheumatol       Date:  2005-09-20       Impact factor: 2.980

6.  Protracted familial mediterranean fever arthritis presenting as septic arthritis.

Authors:  Hale Usluer; Zelal Bircan
Journal:  Rheumatol Int       Date:  2007-03-27       Impact factor: 2.631

7.  Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation.

Authors:  Rami A Jarjour; Reem Dodaki
Journal:  Mol Biol Rep       Date:  2010-09-16       Impact factor: 2.316

Review 8.  Familial Mediterranean fever and seronegative arthritis.

Authors:  Nurullah Akkoc; Ahmet Gul
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

Review 9.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

10.  The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study.

Authors:  Muhammet Cinar; Ayhan Dinc; Ismail Simsek; Hakan Erdem; Bayram Koc; Salih Pay; Yusuf Tunca; Selim Kilic; Davud Gul
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.